Free Trial
NASDAQ:SAVA

Cassava Sciences (SAVA) Stock Price, News & Analysis

Cassava Sciences logo
$2.38 +0.07 (+2.81%)
As of 03:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cassava Sciences Stock (NASDAQ:SAVA)

Key Stats

Today's Range
$2.26
$2.40
50-Day Range
$1.75
$2.70
52-Week Range
$1.15
$33.98
Volume
437,762 shs
Average Volume
1.39 million shs
Market Capitalization
$114.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Hold

Company Overview

Cassava Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

SAVA MarketRank™: 

Cassava Sciences scored higher than 35% of companies evaluated by MarketBeat, and ranked 768th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cassava Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Cassava Sciences has received no research coverage in the past 90 days.

  • Read more about Cassava Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Cassava Sciences are expected to grow in the coming year, from ($3.97) to ($0.62) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cassava Sciences is -0.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cassava Sciences is -0.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cassava Sciences has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Cassava Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    13.40% of the float of Cassava Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cassava Sciences has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Cassava Sciences has recently increased by 0.64%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cassava Sciences does not currently pay a dividend.

  • Dividend Growth

    Cassava Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.40% of the float of Cassava Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cassava Sciences has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Cassava Sciences has recently increased by 0.64%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Cassava Sciences has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cassava Sciences this week, compared to 6 articles on an average week.
  • Search Interest

    Only 4 people have searched for SAVA on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Cassava Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cassava Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.40% of the stock of Cassava Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 38.05% of the stock of Cassava Sciences is held by institutions.

  • Read more about Cassava Sciences' insider trading history.
Receive SAVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SAVA Stock News Headlines

BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
Cassava Sciences Announces Positive Preclinical Results
See More Headlines

SAVA Stock Analysis - Frequently Asked Questions

Cassava Sciences' stock was trading at $2.36 at the beginning of the year. Since then, SAVA stock has increased by 0.6% and is now trading at $2.3750.

Cassava Sciences, Inc. (NASDAQ:SAVA) released its quarterly earnings data on Thursday, August, 14th. The company reported ($0.18) earnings per share (EPS) for the quarter.

Shares of Cassava Sciences split before market open on Thursday, December 21st 2023.The 14-10 split was announced on Thursday, December 21st 2023. The newly issued shares were issued to shareholders after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the split would have 140 shares after the split.

Top institutional investors of Cassava Sciences include JPMorgan Chase & Co. (1.57%), Geode Capital Management LLC (1.08%), Walleye Trading LLC and Group One Trading LLC. Insiders that own company stock include Eric Schoen and James William Kupiec.
View institutional ownership trends
.

Shares of SAVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cassava Sciences investors own include Waste Connections (WCN), Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/14/2025
Today
8/28/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SAVA
CIK
1069530
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$2.00
Low Price Target
$2.00
Potential Upside/Downside
-13.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.55)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.34 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-66.16%
Return on Assets
-53.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.43
Quick Ratio
2.43

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.82 per share
Price / Book
1.27

Miscellaneous

Outstanding Shares
48,310,000
Free Float
47,149,000
Market Cap
$111.60 million
Optionable
Optionable
Beta
-2.05

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:SAVA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners